SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-014815
Filing Date
2018-10-23
Accepted
2018-10-23 17:22:09
Documents
7
Period of Report
2018-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 58222
2 ex4-1.htm EX-4.1 92349
3 ex10-1.htm EX-10.1 220518
4 ex10-2.htm EX-10.2 61679
5 ex10-3.htm EX-10.3 26135
6 ex10-4.htm EX-10.4 249152
7 ex10-5.htm EX-10.5 31330
  Complete submission text file 0001493152-18-014815.txt   740852
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53832 | Film No.: 181134778
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9